BONTRIL PDM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bontril Pdm, and what generic alternatives are available?
Bontril Pdm is a drug marketed by Valeant and is included in one NDA.
The generic ingredient in BONTRIL PDM is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bontril Pdm
A generic version of BONTRIL PDM was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
Summary for BONTRIL PDM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Clinical Trials: | 2 |
Patent Applications: | 1,999 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BONTRIL PDM at DailyMed |
Recent Clinical Trials for BONTRIL PDM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Kentucky | Phase 1 |
National Institute on Drug Abuse (NIDA) | Phase 1 |
William Stoops | Phase 1 |
US Patents and Regulatory Information for BONTRIL PDM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant | BONTRIL PDM | phendimetrazine tartrate | TABLET;ORAL | 085272-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |